Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 8, 2025 • 4:00 PM ET

Date/Time Source News Release
06/03/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio
05/21/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update
05/02/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium
04/28/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System
04/21/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
04/09/2025 04:05 PM EDT GlobeNewswire ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market
04/07/2025 04:05 PM EDT GlobeNewswire ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update
03/23/2025 06:59 PM EDT GlobeNewswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AVTE, RSLS on Behalf of Shareholders
03/10/2025 08:31 AM EDT GlobeNewswire ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
02/25/2025 08:31 AM EST GlobeNewswire ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX
Page